The Thyroid

  • Kenneth A. Woeber
  • Lewis E. Braverman


This chapter will focus on those advances relating to the thyroid that have been reported during 1976 and early 1977 and that have particular impact with respect to human physiology and disease. We elected to retain the organizational format that we employed last year in the hope that over time it will readily permit a longitudinal review of a given general area.


Thyroid Hormone Antithyroid Drug Primary Hypothyroidism Systolic Time Interval Thyrotoxic Periodic Paralysis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parker, D. C., Pekary, A. E., and Hershman, J. M., 1976, Effect of normal and reversed sleep-wake cycles upon nyctohermeral rhythmicity of plasma thyrotropin: Evidence suggestive of an inhibitory influence in sleep, J. Clin. Endocrinol. Metab. 43:318–329.PubMedCrossRefGoogle Scholar
  2. 2.
    Weeke, J., and Laurberg, P., 1976, Diurnal TSH variations in hypothyroidism,J.Clin. Endocrinol. Metab. 43:32–37.PubMedCrossRefGoogle Scholar
  3. 3.
    Gordin, A., Arimura, A., and Schally, A. V., 1976, Effect of thyroid hormone excess and deficiency on serum thyrotropin in rats immunized passively with antiserum to somatostatin, Proc. Soc. Exp. Biol. Med. 153:319–323.PubMedGoogle Scholar
  4. 4.
    Arimura, A., and Schally, A. V., 1976, Increase in basal and thyrotropin-releasing hormone (TRH)-stimulated secretion of thyrotropin (TSH) by passive immunization with antiserum to somatostatin in rats, Endocrinology 98:1069–1072.PubMedCrossRefGoogle Scholar
  5. 5.
    Re, R. N., Kourides, I. A., Ridgway, E. C., Weintraub, B. D., and Maloof, F., 1976, The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin, J. Clin. Endocrinol. Metab. 43:338–346.PubMedCrossRefGoogle Scholar
  6. 6.
    Ramey, J. N., Burrow, G. N., Spaulding, S. W., Donabedian, R. K., Speroff, L., and Frantz, A. G., 1976, The effect of aspirin and indomethacin on the TRH response in man,J. Clin. Endocrinol. Metab. 43:107–114.PubMedCrossRefGoogle Scholar
  7. 7.
    Maeda, M., Kuzuya, N., Masuyama, Y., Imai, Y., Ikeda, H., Uchimura, H., Matsuzaki, F., Kumagai, L. F., and Nagataki, S., 1976, Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism,J. Clin. Endocrinol. Metab. 43:10–17.PubMedCrossRefGoogle Scholar
  8. 8.
    Nicod, P., Burger, A., Strauch, G., Vagenakis, A. G., and Braverman, L. E., 1976, The failure of physiologic doses of reverse T3 to affect thyroid-pituitary function in man,J. Clin. Endocrinol. Metab. 43:478–481.PubMedCrossRefGoogle Scholar
  9. 9.
    White, N., Jeffcoate, S. L., Griffiths, E. C., and Hooper, K. C., 1976, Effect of thyroid status on the thyrotrophin-releasing hormone-degrading activity of rat serum, J. Endocrinol. 71:13–19.PubMedCrossRefGoogle Scholar
  10. 10.
    Bauer, K., 1976, Regulation of degradation of thyrotropin-releasing hormone by thyroid hormones, Nature (London) 259:591–593.CrossRefGoogle Scholar
  11. 11.
    Dupont, A., Labrie, F., Levasseur, L., Dussault, J.-H., and Schally, A. V., 1976, Effect of thyroxine on the inactivation of thyrotropin-releasing hormone by rat and human plasma, Clin. Endocrinol. 5:323–330.CrossRefGoogle Scholar
  12. 12.
    Neary, J. T., Kieffer, J. D., Federico, P., Mover, H., Maloof, F., and Soodak, M., 1976, Thyrotropin releasing hormone: Development of inactivation system during maturation of the rat, Science 193:403–405.PubMedCrossRefGoogle Scholar
  13. 13.
    Mitsuma, T., Hirooka, Y., and Nihei, N., 1976, Radioimmunoassay of thyrotropin releasing hormone in human serum and its clinical application, Acta Endocrinol. 83:225–235.PubMedGoogle Scholar
  14. 14.
    Azukizawa, M., Murata, Y., Ikenoue, T., Martin, C. B., and Hershman, J. M., 1976, Effect of thyrotropin-releasing hormone on secretion of thyrotropin, prolactin, thyroxine, and triiodothyronine in pregnant and fetal rhesus monkeys,J. Clin. Endocrinol. Metab. 43:1020–1028.PubMedCrossRefGoogle Scholar
  15. 15.
    Zarate, A., Villalobos, H., Canales, E. S., Soria, J, Arcovedo, F., and Mac-Gregor, C., 1976, The effect of oral administration of thyrotropin-releasing hormone on lactation,J.Clin. Endocrinol Metal. 43:301–305.CrossRefGoogle Scholar
  16. 16.
    Tyson, J. E., Perez, A., and Zanartu, J., 1976, Human lactational response to oral thyrotropin releasing hormone,J. Clin. Endocrinol. Metab. 43:760–768.PubMedCrossRefGoogle Scholar
  17. 17.
    Yu, S., Friedman, Y., Richman, R., and Burke, G., 1976, Altered thyroidal responsivity to thyrotropin induced by circulating thyroid hormones: A “short-loop” regulatory mechanism?,J. Clin. Invest. 57:745–755.PubMedCrossRefGoogle Scholar
  18. 18.
    Gafni, M., Saddok, C., Sirkis, N., and Gross, J., 1977, The mechanism of damping of the serum thyroxine and triiodothyronine levels caused by increasing thyrotropin dosage in mice, Endocrinology 100:1186–1191.PubMedCrossRefGoogle Scholar
  19. 19.
    Gluzman, B. E., Varela, A. S., and Niepomniszeze, H., 1976, Altered thyroidal responsivity to TSH: Probable clinical example of a newly proposed “short-loop” regulatory mechanism, Rev. Biol. Med. Nucl. 8:75–78.Google Scholar
  20. 20.
    Shuman, S. J., Zor, U., Chayoth, R., and Field, J. B., 1976, Exposure of thyroid slices to thyroid-stimulating hormone induces refractoriness of the cyclic AMP system to subsequent hormone stimulation, J. Clin. Invest. 57:1132–1141.PubMedCrossRefGoogle Scholar
  21. 21.
    Field, J. B., Bloom, G., Chou, C.-Y., and Kerins, M. E., 1977, Inhibition of thyroid-stimulating hormone stimulation of protein kinase, glucose oxidation, and phospholipid synthesis in thyroid slices previously exposed to the hormone,J. Clin. Invest. 59: 659–665.PubMedCrossRefGoogle Scholar
  22. 22.
    Rapoport, B., 1976, Dog thyroid cells in monolayer tissue culture: Adenosine 3′,5′-cyclic monophosphate response to thyrotropic hormone, Endocrinology 98:1189–1197.PubMedCrossRefGoogle Scholar
  23. 23.
    Thompson, M. E., Orczyk, G. P., and Hedge, G. A., 1972, In vivo inhibition of thyroid secretion by indomethacin, Endocrinology 100:1060–1067.CrossRefGoogle Scholar
  24. 24.
    Rapoport, B., and Adams, R. J., 1976, Induction of refractoriness to thyrotropin stimulation in cultured thyroid cells: Dependence on new protein synthesis,J. Biol. Chem. 251:6653–6661.PubMedGoogle Scholar
  25. 25.
    Spaulding, S. W., 1977, Effect of thyrotropin on ornithine decarboxylase and of polyamines on RNA polymerase in the thyroid, Endocrinology 100:1039–1946.PubMedCrossRefGoogle Scholar
  26. 26.
    Pisarev, M. A., and Kleiman de Pisarev, D. L., 1977, Action of cyclic nucleotides on protein and RNA synthesis in the thyroid, Acta Endocrinol. 84:297–302.PubMedGoogle Scholar
  27. 27.
    Sato, A., Hashizume, K., Onaya, T., Miyakawa, M., Makiuchi, M., and Furihata, R., 1976, Effects of biogenic amines on the formation of adenosine 3′,5′-monophosphate in human thyroid slices, Endocrinol. Jpn. 23:319–325.PubMedCrossRefGoogle Scholar
  28. 28.
    Onaya, T., Hashizume, K., Sato, A., Takazawa, K., Akasu, F., and Endo, W., 1977, Evidence for the existence of a histamine H2-receptor in the mouse thyroid, Endocrinology 100:61–66.PubMedCrossRefGoogle Scholar
  29. 29.
    Takasu, N., Sato, S., Tsukui, T., Yamada, T., Miyakawa, M., Makiuchi, M., and Furihata, R., 1976, Comparison of prostaglandin Ei and TSH stimulation of cyclic AMP synthesis in thyroid tissues from euthyroid subjects and thyrotoxic patients,J. Clin. Endocrinol. Metab. 43:69–79.CrossRefGoogle Scholar
  30. 30.
    Davies, T. F., McLachlan, S. M., Povey, P. M., Smith, B. R., and Hall, R., 1977, The influence of propranolol on the thyrotropin receptor, Endocrinology 100:974–979.PubMedCrossRefGoogle Scholar
  31. 31.
    Laurberg, P., 1977, The relative contribution of thyroxine and triiodothyronine to the hormone secretion from the perfused canine thyroid during various degrees of stimulation, Endocrinology 100:656–662.PubMedCrossRefGoogle Scholar
  32. 32.
    Clark, O. H., Lambert, W. R., Cavalieri, R. R., Rapoport, B., Hammond, M. E., and Ingbar, S. H., 1976, Compensatory thyroid hypertrophy after hemi-thyroidectomy in rats, Endocrinology 99:988–995.PubMedCrossRefGoogle Scholar
  33. 33.
    Hashizume, K., Akasu, F., Takazawa, K., Endo, W., and Onaya, T., 1976, The inhibitory effect of acute administration of excess iodide on the formation of adenosine 3′,5′-mo no phosphate induced by thyrotropin in mouse thyroid lobes, Endocrinology 99:1463–1468.PubMedCrossRefGoogle Scholar
  34. 34.
    Rapoport, B., West, M. N., and Ingbar, S. H., 1976, On the mechanism of inhibition by iodine of the thyroid adenylate cyclase response to thyrotropic hormone, Endocrinology 99:11–22.PubMedCrossRefGoogle Scholar
  35. 35.
    Rapoport, B., Adams, R. J., and Rose, M., 1977, Cultured thyroid cell adenosine 3′,5′-cyclic monophosphate response to thyrotropin: Loss and restoration of sensitivity to iodide inhibition, Endocrinology 100:755–764.PubMedCrossRefGoogle Scholar
  36. 36.
    Pisarev, M. A., Aiello, L. O., and Kleiman de Pisarev, D. L., 1976, Action of KI, thyroxine and cyclic AMP on [3H]uridine incorporation into the RNA of thyroid slices, Acta Endocrinol. 83:313–320.PubMedGoogle Scholar
  37. 37.
    Pisarev, M. A., and Aiello, L. O., 1976, Studies on the mechanism of action of potassium iodide on thyroid protein biosynthesis, Acta Endocrinol 82:298–305.PubMedGoogle Scholar
  38. 38.
    Bagchi, N., Brown, T., Shivers, B., and Mack, R. E., 1977, Effect of inorganic iodide on thyroglobulin hydrolysis in cultured thyroid glands, Endocrinology 100:1002–1007.PubMedCrossRefGoogle Scholar
  39. 39.
    Yukimura, Y., Ikejiri, K., Kojima, A., and Yamada, T., 1976, Effect of excess iodide and other anions on thyroid hormone secretion in normal or hypoph-ysectomized rats treated with graded doses of thyroid hormone, Endocrinology 99:541–548.PubMedCrossRefGoogle Scholar
  40. 40.
    Riesco, G., Taurog, A., Larsen, P. R., and Krulich, L., 1977, Acute and chronic responses to iodine deficiency in rats, Endocrinology 100:303–313.PubMedCrossRefGoogle Scholar
  41. 41.
    Taurog, A., Riesco, G., and Larsen, P. R., 1976, Formation of 3,3′-diiodothy-ronine and 3′,5′-triiodothyronine (reverse T3) in thyroid glands of rats and in enzymatically iodinated thyroglobulin, Endocrinology 99:281–290.PubMedCrossRefGoogle Scholar
  42. 42.
    Riesco, G., Taurog, A., and Larsen, P. R., 1976, Variations in the response of the thyroid gland of the rat to different low-iodine diets: Correlation with iodine content of diet, Endocrinology 99:270–280.PubMedCrossRefGoogle Scholar
  43. 43.
    Fragu, P., and Nataf, B. M., 1976, Thyroid peroxidase activity in iodine deficient rats, Acta Endocrinol. 82:535–543.PubMedGoogle Scholar
  44. 44.
    Vagenakis, A. G., and Braverman, L. E., 1975, Adverse effects of iodides on thyroid function, Med. Clin. North Am. 59:1075–1088.PubMedGoogle Scholar
  45. 45.
    Croxson, M. S., Gluckman, P. D., and Ibbertson, H. K., 1976, The acute thyroidal response to iodized oil in severe endemic goiter, J. Clin. Endocrinol. Metab. 42:926–930.PubMedCrossRefGoogle Scholar
  46. 46.
    Ikeda, H., and Nagataki, S., 1976, Augmentation of thyrotropin responses to thyrotropin-releasing hormone following inorganic iodide, Endocrinol Jpn. 23:431–433.PubMedCrossRefGoogle Scholar
  47. 47.
    Lamas, L., and Taurog, A., 1977, The importance of thyroglobulin structure in thyroid peroxidase-catalyzed conversion of diiodotyrosine to thyroxine, Endocrinology 100:1129–1136.PubMedCrossRefGoogle Scholar
  48. 48.
    Kawada, J., Shindo, T., and Yoshimurar Y., 1976, Further study of the mechanism of thyroid hormone secretion in an in vitro model system: Direct evidence for fusion of lysosomes with thyroglobulin liposomes, Endocrinology 98:1425–1429.PubMedCrossRefGoogle Scholar
  49. 49.
    Pelletier, G., Puviani, R., and Dussault, J. H., 1976, Electron microscope immunohistochemical localization of thyroglobulin in the rat thyroid gland, Endocrinology 98:1253–1259.PubMedCrossRefGoogle Scholar
  50. 50.
    Taurog, A., 1976, The mechanism of action of the thioureylene antithyroid drugs, Endocrinology 98:1031–1046.PubMedCrossRefGoogle Scholar
  51. 51.
    Nagasaka, A., and Hidaka, H., 1976, Effect of antithyroid agents 6-propyl-2-thiouracil and 1-methyl-2-mercaptoimidazole on human thyroid iodide peroxidase, J. Clin. Endocrinol Metab. 43:152–158.PubMedCrossRefGoogle Scholar
  52. 52.
    Williams, J. A., 1976, In vitro studies on the nature of vinblastine inhibition of thyroid secretion, Endocrinology 98:1351–1358.PubMedCrossRefGoogle Scholar
  53. 53.
    Green, W. L., 1976, Induction of a coupling defect in rats during inhibition of tyrosine dehalogenase, Endocrinology 98:10–19.PubMedCrossRefGoogle Scholar
  54. 54.
    Pommier, J., Tourniaire, J., Rahmoun, B., Dème, D., Pallo, D., Bornet, H., and Nunez, J., 1976, Thyroid iodine organification defects: A case with lack of thyroglobulin iodination and a case without any peroxidase activity. J. Clin. Endocrinol Metab. 42:319–329.PubMedCrossRefGoogle Scholar
  55. 55.
    Cuestas, R. A., Lindall, A., and Engel, R. R., 1976, Low thyroid hormones and respiratory-distress syndrome of the newborn, N. Engl J. Med. 295:297–302.PubMedCrossRefGoogle Scholar
  56. 56.
    Burger, A., Nicod, P., Suter, P., Vallotton, M. B., Vagenakis, A., and Braverman, L., 1976, Reduced active thyroid hormone levels in acute illness, Lancet 1:653–655.PubMedCrossRefGoogle Scholar
  57. 57.
    Naeiji, R., Clumeck, N., Somers, G., Vanhaelst, L., and Golstein, J., 1976, Thyroid hormones in serious non-thyroidal illness, Lancet 1:1070–1971.Google Scholar
  58. 58.
    Brandt, M. R., Kehlet, H., Skovsted, L., and Hansen, J. M., 1976, Rapid decrease in plasma-triiodothyronine during surgery and epidural analgesia independent of afferent neurogenic stimuli and of Cortisol, Lancet 2:1333–1335.PubMedCrossRefGoogle Scholar
  59. 59.
    Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., and Vallotton, M. B., 1976, Effect of aminodarone on serum triidothyron-ine, reverse triiodothyronine, thyroxin and thyrotropin: A drug influencing peripheral metabolism of thyroid hormones,J. Clin. Invest 58:255–259.PubMedCrossRefGoogle Scholar
  60. 60.
    Bürgi, H., Wimpfheimer, C., Burger, A., Zaunbauer, W., Rosier, H., and Lemarchand-Béraud, T., 1976, Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents, J. Clin. Endocrinol. Metab. 43:1203–1210.PubMedCrossRefGoogle Scholar
  61. 61.
    Verhoeven, R. P., Visser, T. J., Docter, R., Hennemann, G., and Schalekamp, M. A. D. H., 1977, Plasma thyroxine, 3,3′,5-triiodothyronine and 3,3′,5′-triiodothyronine during β-adrenergie blockade in hyperthyroidism, J. Clin. Endocrinol. Metab. 44:1002–1005.PubMedCrossRefGoogle Scholar
  62. 62.
    Danforth, E., Jr., Tyzbir, E. D., Horton, E. S., Sims, E. A. H., Burger, A. G., Braverman, L. E., Vagenakis, A. G., and Ingbar, S. H., 1976, Reciprocal changes in serum triiodothyronine (T3) and reverse (r T3) induced by altering the carbohydrate content of the diet, Clin. Res. 24:271A.Google Scholar
  63. 63.
    Spaulding, S.W., Chopra, I. J., Sherwin, R. S., and Lyall, S. S., 1976, Effect of caloric restriction and dietary composition on serum T3 and reverse T3 in man, J. Clin. Endocrinol. Metab. 42:197–200.PubMedCrossRefGoogle Scholar
  64. 64.
    Balsam, A., Sexton, F. C., and Ingbar, S. H., 1976, In vitro generation of T3 from T4 by rat liver: Reversible inhibition by starvation and diabetes mellitus, Program Am. Thyroid Assoc, P. T-16.Google Scholar
  65. 65.
    Harris, A., Fang, S., Ingbar, S., Braverman, L., and Vagenakis, A., 1977, Effect of carbohydrate, protein, and fat infusion on the hepatic T3 generation in the fasted rat, Clin. Res. 25:463A.Google Scholar
  66. 66.
    Bray, G. A., Fisher, D. A., and Chopra, I. J., 1976, Relation of thyroid hormones to body weight, Lancet 1:1206–1208.PubMedCrossRefGoogle Scholar
  67. 67.
    Hervas, F., Morreale de Escobar, G., and Escobar del Rey, F., 1976, Conversion of L-thyroxine to triiodo-L-thyronine and biological activity of L-thyrox-ine as measured by changes in growth hormone, Endocrinology 98:77–83.PubMedCrossRefGoogle Scholar
  68. 68.
    Larsen, P. R., and Frumess, R. D., 1977, Comparison of the biological effects of thyroxine and triiodothyronine in the rat, Endocrinology 100:980–988.PubMedCrossRefGoogle Scholar
  69. 69.
    Croxson, M. S., and Ibbertson, H. K., 1977, Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa, J. Clin. Endocrinol. Metab. 44:167–174.PubMedCrossRefGoogle Scholar
  70. 70.
    Boyar, R. M., Hellman, L. D., Roffwarg, H., Katz, J., Zumoff, B., O’Connor, J., Bradlow, H. L., and Fukushima, D. K., 1977, Cortisol secretion and metabolism in anorexia nervosa, N. Engl. J. Med. 296:190–193.PubMedCrossRefGoogle Scholar
  71. 71.
    Bradlow, H. L., Boyar, R. M., O’Connor, J., Zumoff, B., and Hellman, L., 1976, Hypothyroid-like alterations in testosterone metabolism in anorexia nervosa, J. Clin. Endocrinol. Metab. 43:571–574.PubMedCrossRefGoogle Scholar
  72. 72.
    Chopra, I. J., 1976, An assessment of daily production and significance of thyroidal secretion of 3,3′,5′-triiodothyronine (reverse T3) in man, J. Clin. Invest. 58:32–40.PubMedCrossRefGoogle Scholar
  73. 73.
    Burman, K. D., Dimond, R. C., Wright, F. D., Earll, J. M., Bruton, J., and Wartofsky, L., 1977, A radioimmunoassay for 3,3′,5′-triiodothyronine (reverse T3): Assessment of thyroid gland content and serum measurements in conditions of normal and altered thyroidal economy and following administration of thyrotropin releasing hormone (TRH) and thyrotropin (TSH),J. Clin, Endocrinol. Metab. 44:660–672.CrossRefGoogle Scholar
  74. 74.
    Westgren, U., Melander, A., Ingemansson, S., Burger, A., Tibblin, S., and Wahlin, E., 1977, Secretion of thyroxine, 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine in euthyroid man, Acta Endocrinol. 84: 281–289.PubMedGoogle Scholar
  75. 75.
    Ingbar, S. H., and Braverman, L. E., 1975, Active form of the thyroid hormone, Annu. Rev. Med. 26:443–449.PubMedCrossRefGoogle Scholar
  76. 76.
    Einsenstein, A., Hagg, S., Vagenakis, A., Fang, S., Ransil, B., Braverman, L., and Ingbar, S., 1977, Observations on the peripheral metabolism of 3,3′,5′-triiodothyronine (reverse T3, rT3) in fed and fasted patients, Clin. Res. 25:294A.Google Scholar
  77. 77.
    Suda, A., Chambers, J., Jr., Thurston, C., andPittman, C., 1977, Thyroid hormone kinetics in the fasting and diabetic subjects, Clin. Res. 25:516A.Google Scholar
  78. 78.
    Gavin, L., Castle, J., McMahon, F., Martin, P., Hammond, M., and Cavalieri, R. R., 1977, Extrathyroidal conversion of thyroxine to 3,3′,5′-triiodothyronine (reverse-T3) and to 3,5,3′-triiodothyronine (T3) in humans, J. Clin. Endocrinol. Metab. 44:733–742.PubMedCrossRefGoogle Scholar
  79. 79.
    Smallridge, R. C., Wartofsky, L., Desjardins, R. E., and Burman, K. D., 1977, Reverse T3 (rT3) production rates in thyrotoxic, euthyroid, and hypothyroid subjects, Clin. Res. 25:302A.Google Scholar
  80. 80.
    Nicod, P., Burger, A., Staeheli, V., and Vallotton, M. B., 1976, A radioimmunoassay for 3,3′,5′-triiodo-L.thyronine in unextracted serum: Method and clinical results, J. Clin. Endocrinol. Metab. 42:823–829.PubMedCrossRefGoogle Scholar
  81. 81.
    Ratcliffe, W. A., Marshall, J., and Ratcliffe, J. G., 1976, The radioimmunoassay of 3,3′,5′-triiodothyronine (reverse T3) in unextracted human serum, Clin. Endocrinol. 5:631–641.CrossRefGoogle Scholar
  82. 82.
    Griffiths, R. S., Black, E. G., and Hoffenberg, R., 1976, Measurement of serum 3,3′,5′-(reverse) T3, with comments on its derivation, Clin. Endocrinol. 5:679–685.CrossRefGoogle Scholar
  83. 83.
    Gordon, A., and Gross, J., 1976, An inter-laboratory comparison of total serum triiodothyronine determination, Acta Endocrinol. 83:539–548.PubMedGoogle Scholar
  84. 84.
    Smak, A. G. H., Ross, H. A., and Kloppenborg, P. W. G., 1977, Seasonal variations in serum T3 and T4 levels in man, J. Clin. Endocrinol. Metab. 44:998–1001.CrossRefGoogle Scholar
  85. 85.
    Papavasiliou, S. S., Martial, J. A., Leetham, K. R., and Baxter, J. D., 1976, Thyroid hormone-like actions of reverse T3 and 3,3′-diiodothyronine (3,3′-T2), Program Am. Thyroid Assoc. P. T-18.Google Scholar
  86. 86.
    Chopra, I. J., 1976, Extrathyroid conversion of T4 to T3 in vitro: Evidence that reverse T3 is a potent inhibitor of T3 production, Clin. Res. 24:426A.Google Scholar
  87. 87.
    Chopra, I. J., Carlson, H. E., and Solomon, D. H., 1976, Comparison of TSH-suppressive effects of various thyroid hormones in vitro, Clin. Res. 24:270A.Google Scholar
  88. 88.
    Fishman, N., Huang, Y. P., Tergis, D. C., and Rivlin, R. S., 1977, Relation of triiodothyronine and reverse triiodothyronine administration in rats to hepatic L-triiodothyronine aminotransferase activity, Endocrinology 100:1055–1059.PubMedCrossRefGoogle Scholar
  89. 89.
    Lindstedt, G., Lundberg, P.-A., Olsson, A., and Karlsson, K., 1976, Reverse triiodothyronine in screening for congenital hypothyroidism, Lancet 2:1142.PubMedCrossRefGoogle Scholar
  90. 90.
    Rudolph, M., Sakurada, T., Vagenakis, A., Fang, S., Braverman, L., and Ingbar, S., 1976, Demonstration of sequential monodeiodination as the major pathway of iodothyronine metabolism, Clin. Res. 24:429A.Google Scholar
  91. 91.
    Wu, S.-Y., Chopra, I. J., Nakamura, Y., Solomon, D. H., and Bennett, L. R., 1976, A radioimmunoassay for measurement of 3,3′-L-diiodothyronine (T2), J. Clin. Endocrinol. Metab. 43:682–685.PubMedCrossRefGoogle Scholar
  92. 92.
    Burman, K. D., Read, J., Dimond, R. C., Strum, D., Wright, F. D., Patow, W., Earll, J. M., and Wartofsky, L., 1976, Measurements of 3,3′,5′-L-triiodothyronine (reverse T3), 3,3′-L-diiodothyronine, T3, and T4 in human amniotic fluid and in cord and maternal serum,J. Clin. Endocrinol Metab. 43:1351–1359.PubMedCrossRefGoogle Scholar
  93. 93.
    Gavin, L. A., Hammond, M., Castle, J. N., and Cavalieri, R. R., 1977, 3,3′-diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man, Clin. Res. 25:294A.Google Scholar
  94. 94.
    VanHerle, A. J., Chopra, I. J., Hershman, J. M., and Hornabrook, R. W., 1976, Serum thyroglobulin in inhabitants of an endemic goiter region in New Guinea,J. Clin. Endocrinol. Metab. 43:512–516.PubMedCrossRefGoogle Scholar
  95. 95.
    Schneider, A. B., Favus, M. J., Stachura, M. E., Arnold, J. E., Ryo, U., Pinsky, S., Colman, M., Arnold, M. J., and Frohman, L. A., 1977, Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation, Ann. Intern. Med. 86:29–34.PubMedGoogle Scholar
  96. 96.
    Takeda, Y., and Kriss, J. P., 1977, Radiometric measurement of thyroglobulinan tithyroglobu! m immune complex in human serum,J. Clin. Endocrinol. Metab. 44:46–55.PubMedCrossRefGoogle Scholar
  97. 97.
    Gershengorn, M. C., Larsen, P. R., and Robbins, J., 1976, Radioimmunoassay for serum thyroxine-binding globulin: Results in normal.subjects and in patients with hepatocellular carcinoma, J. Clin. Endocrinol. Metab. 42:907–911.PubMedCrossRefGoogle Scholar
  98. 98.
    Glinoer, D., McGuire, R. A., Gershengorn, M. C., Robbins, J., and Berman, M., 1977, Effects of estrogen on thyroxine-binding globulin metabolism in rhesus monkeys, Endocrinology 100:9–17.PubMedCrossRefGoogle Scholar
  99. 99.
    Glinoer, D., Gershengorn, M. C., Dubois, A., and Robbins, J., 1977, Stimulation of thyroxine-binding globulin synthesis by isolated rhesus monkey hepatocytes after in vivoβ-estradiol administration, Endocrinology 100:807–813.PubMedCrossRefGoogle Scholar
  100. 100.
    Refetoff, S., Fang, V. S., Marshall, T. S., and Robin, N. E., 1976, Metabolism of thyroxine-binding globulin in man: Abnormal rate of synthesis in inherited thyroxine-binding globulin deficiency and excess,J. Clin. Invest. 57:485–495.PubMedCrossRefGoogle Scholar
  101. 101.
    Woeber, K. A., 1976, A granule-associated L-thyroxine deiodinating system in the human leukocyte, Endocrinology 98:802–806.PubMedCrossRefGoogle Scholar
  102. 102.
    Woeber, K. A., 1976, Influence of superoxide dismutase and catalase on the stimulation by phagocytosis of L-thyroxine and L-triiodothyronine deiodina-tion in the human leukocyte, Endocrinology 99:887–890.PubMedCrossRefGoogle Scholar
  103. 103.
    Woeber, K. A., 1977, Observations concerning the binding of L-triiodothyronine in the human polymorphonuclear leukocyte, J. Clin. Endocrinol. Metab. 44:62–68.PubMedCrossRefGoogle Scholar
  104. 104.
    Zaninovich, A. A., 1976, Reciprocal effects of thyroxine and triiodothyronine on their deiodination by rat tissues in vitro, Acta Endocrinol. 82:510–516.PubMedGoogle Scholar
  105. 105.
    Japundzic, M. M., Bastomsky, C. H., and Japundzic, I. P., 1976, Enchanced biliary thyroxine excretion in rats treated with pregnenolone-16α-carbonitrile, Acta Endocrinol. 81:110–119.PubMedGoogle Scholar
  106. 106.
    Leffert, H. L., and Alexander, N. M., 1976, Thyroid hormone metabolism during liver regeneration in rats, Endocrinology 98:1241–1247.PubMedCrossRefGoogle Scholar
  107. 107.
    Langer, P., Kokesova, H., and Gschwendtova, K., 1976, Acute redistribution of thyroxine after the administration of univalent anions, salicylate, theophylline and barbiturates in rats, Acta Endocrinol. 81:516–524.PubMedGoogle Scholar
  108. 108.
    Balsam, A., and Sexton, F. C., 1976, Thyroid hormone regulation of extra-thyroidal iodoproteins, Endocrinology 98:476–481.PubMedCrossRefGoogle Scholar
  109. 109.
    Goslings, B., Schwartz, H. L., Dillmann, W., Surks, M. I., and Oppenheimer, J. H., 1976, Comparison of the metabolism and distribution of L-triiodothyronine and triiodothyroacetic acid in the rat: A possible explanation of differential hormonal potency, Endocrinology 98:666–675.PubMedCrossRefGoogle Scholar
  110. 110.
    Karlsson, F. A., Wibell, L., and Wide, L., 1977, Hypothyroidism due to thyroid-hormone-binding antibodies, N. Engl. J. Med. 296:1146–1148.PubMedCrossRefGoogle Scholar
  111. 111.
    Wu, S.-Y., and Green, W. L., 1976, Triiodothyronine (T3)-binding immunoglobulins in a euthyroid woman: Effects on measurement of T3 (RIA) and on T3 turnover, J. Clin. Endocrinol. Metab. 42:642–652.PubMedCrossRefGoogle Scholar
  112. 112.
    Samuels, H. H., and Shapiro, L. E., 1976, Thyroid hormone stimulates de novo growth hormone synthesis in cultured GHi cells: Evidence for the accumulation of a rate limiting RNA species in the induction process, Proc. Natl. Acad. Sci. U.S.A. 73:3369–3373.PubMedCrossRefGoogle Scholar
  113. 113.
    Samuels, H. H., Stanley, F., and Shapiro, L. E., 1976, Dose-dependent depletion of nuclear receptors by L-triiodothyronine: Evidence for a role in induction of growth hormone synthesis in cultured GHi cells, Proc. Natl. Acad. Sci. U.S.A. 73:3877–3881.PubMedCrossRefGoogle Scholar
  114. 114.
    Sterling, K., Lazarus, I. H., Milch, P. O., and Rose, H. G., 1976, Nature and significance of the mitochondrial T3 receptor, Program Am. Thyroid Assoc. p. T-7.Google Scholar
  115. 115.
    Asano, Y., Lieberman, U. A., and Edelman, I. S., 1976, Thyroid thermoge-nesis: Relationships between Na+-dependent respiration and Na++K+-adenosine triphosphatase activity in rat skeletal muscle, J. Clin. Invest. 57:368–379.PubMedCrossRefGoogle Scholar
  116. 116.
    Hamada, S., and Fukase, M., 1976, Demonstration and some properties of cytosal-binding proteins for thyroxine and triiodothyronine in human liver, J. Clin. Endocrinol. Metab. 42:302–308.PubMedCrossRefGoogle Scholar
  117. 117.
    Solomon, D. H., and Kleeman, K. E., 1976, Concepts of pathogenesis of Graves’ disease, Adv. Intern. Med. 22:273–299.Google Scholar
  118. 118.
    Volpé, R., 1976, The pathogenesis of Graves disease, Compr. Ther. 2:43–52.PubMedGoogle Scholar
  119. 119.
    Irvine, W. J., and Toft, A. D., 1976, The diagnosis and treatment of thyrotoxicosis, Clin. Endocrinol. 5:687–707.CrossRefGoogle Scholar
  120. 120.
    Orgiazzi, J., Williams, D. E., Chopra, I. J., and Solomon, D. H., 1976, Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves’ disease,J. Clin. Endocrinol. Metab. 42:341–354.PubMedCrossRefGoogle Scholar
  121. 121.
    McKenzie, J. M., and Zakarija, M., 1976, A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves’ disease,J. Clin. Endocrinol. Metab. 42:778–781.PubMedCrossRefGoogle Scholar
  122. 122.
    Bryson, J. M., Joasoo, A., and Turtle, J. R., 1976, The thyrotrophin receptor in human thyroid plasma membranes: Effect of serum immunoglobulins, Acta Endocrinol. 83:528–538.PubMedGoogle Scholar
  123. 123.
    Ong, M., Malkin, D. G., Tay, S. K., and Malkin, A., 1976, Activation of thyroid adenyl cyclase by antisera to thyroid plasma membrane preparations, Endocrinology 98:880–885.PubMedCrossRefGoogle Scholar
  124. 124.
    Clague, R., Mukhtar, E. D., Pyle, G. A., Nutt, J., Clark, F., Scott, M., Evered, D., Rees Smith, B., and Hall, R., 1976, Thyroid-stimulating immunoglobulins and the control of thyroid function,J. Clin. Endocrinol. Metab. 43:550–556.PubMedCrossRefGoogle Scholar
  125. 125.
    Solomon, D. H., Chopra, I. J., Chopra, U., and Smith, F. J., 1977, Identification of subgroups of euthyroid Graves’s ophthalmopathy, N. Engl. J. Med. 296:181–186.PubMedCrossRefGoogle Scholar
  126. 126.
    Christy, J. H., and Morse, R. S., 1977, Hypothyroid Graves’ disease, Am. J. Med. 62:291–296.PubMedCrossRefGoogle Scholar
  127. 127.
    Mullin, B. R., Levinson, R. E., Friedman, A., Henson, D. E., Winand, R. J., and Kohn, L. D., 1977, Delated hypersensitivity in Graves’ disease and exophthalmos: Identification of thyroglobulin in normal human orbital muscle, Endocrinology 100:351–366.PubMedCrossRefGoogle Scholar
  128. 128.
    Knox, A. J. S., von Westarp, C., Row, V. V., and Volpé, R., 1976, Thyroid antigen stimulates lymphocytes from patients with Graves’ disease to produce thyroid-stimulating immunoglobulin (TSI), J.Clin. Endocrinol. Metab. 43:330–337.CrossRefGoogle Scholar
  129. 129.
    Knox, A. J. S., von Westarp, C., Row, V. V., and Volpé, R., 1976, Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves’ lymphocytes cultured in vitro with pyytohaemagglutinin (PHA), Metabolism 25:1217–1223.PubMedCrossRefGoogle Scholar
  130. 130.
    Amino, N., Miyai, K., Yamamoto, T., Kuro, R., Tanaka, F., Tanizawa, O., and Kumahara, Y., 1977, Transient recurrence of hyperthyroidism after delivery in Graves’ disease,J. Clin. Endocrinol. Metab. 44:130–136.PubMedCrossRefGoogle Scholar
  131. 131.
    Greer, M. A., Kammer, H., and Bouma, D. J., 1976, A simplified short-term technique for treating Graves’ disease with antithyroid drugs, Program Am. Thyroid Assoc, p. T-2.Google Scholar
  132. 132.
    Lumholtz, T. B., Loldrup-Poulsen, D., Siersboek-Nielsen, K., Friis, T., Rogowski, P., Kirkegaard, C., and Molholm Hansen, J. 1977, Outcome of long-term antithyroid treatment of Graves’ disease in relation to iodine intake, Acta Endocrinol. 84:538–541.PubMedGoogle Scholar
  133. 133.
    Martino, E., Pinchera, A., Capiferri, R., Machia, E., Sardano, G., Bartalena, L., Mazzanti, F., and Baschieri, L., 1976, Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following anti-thyroid drug therapy of hyperthyroidism, J. Clin. Endocrinol. Metab. 43:543–549.PubMedCrossRefGoogle Scholar
  134. 134.
    Buerklin, E. M., Schimmel, M., and Utiger, R. D., 1976, Pituitary-thyroid regulation in euthyroid patients with Graves’ disease previously treated with antithyroid drugs,J. Clin. Endocrinol. Metab. 43:419–427.PubMedCrossRefGoogle Scholar
  135. 135.
    Lebacq, E. G., Therasse, G., Schmitz, A., Delannoy, A., and Destailleurs, C., 1976, Subacute thyroiditis, Acta Endocrinol. 81:707–715.PubMedGoogle Scholar
  136. 136.
    Woolf, P. D., and Daly, R., 1976, Thyrotoxicosis with painless thyroiditis, Am. J. Med. 60:73–79.PubMedCrossRefGoogle Scholar
  137. 137.
    Dorfman, S. G., Cooperman, M. T., Nelson, R. L., Depuy, H., Peake, R. L., and Young, R. L., 1977, Painless thyroiditis and transient hyperthyroidism without goiter, Ann. Intern. Med. 86:24–28.PubMedGoogle Scholar
  138. 138.
    Toft, A. D., Irvine, W. J., and Hunter, W. M., 1976, A comparison of plasma TSH levels in patients with diffuse and nodular non-toxic goiter, J. Clin. Endocrinol. Metab. 42:973–976.PubMedCrossRefGoogle Scholar
  139. 139.
    Gemsenjäger, E., Staub, J. J., Girard, J., and Heitz, P. H., 1976, Preclinical hyperthyroidism in multinodular goiter, J. Clin. Endocrinol. Metab. 43:810–816.PubMedCrossRefGoogle Scholar
  140. 140.
    Miyai, K., Tanizawa, O., Yamamoto, T., Azukizawa, M., Kawai, Y., Noguchi, M., Ishibashi, K., and Kumahara, Y., 1976, Pituitary-thyroid function in trophoblastic disease,J. Clin. Endocrinol. Metab. 42:254–259. PubMedCrossRefGoogle Scholar
  141. 141.
    Morley, J. E., Jacobson, R. J., Melamed, J., and Hershman, J. M., 1976, Choriocarcinoma as a cause of thyrotoxicosis, Am. J. Med. 60:1036–1040.PubMedCrossRefGoogle Scholar
  142. 142.
    Nagataki, S., Mizuno, M., Sakamoto, S., Irie, M., Shizunie, K., Nakao, K., Galton, V. A., Arky, R. A., and Ingbar, S. H., 1977, Thyroid function in molar pregnancy,J. Clin. Endocrinol. Metab. 44:254–263.PubMedCrossRefGoogle Scholar
  143. 143.
    Baylis, P. H., 1976, Case of hyperthyroidism due to a chromophobe adenoma, Clin. Endocrinol. 5:145–150.CrossRefGoogle Scholar
  144. 144.
    Reschini, E., Giustina, G., Cantalamessa, L., and Peracchi, M., 1976, Hyperthyroidism with elevated plasma TSH levels and pituitary tumor: Study with somatostatin,J. Clin. Endocrinol. Metab. 43:924–927.PubMedCrossRefGoogle Scholar
  145. 145.
    Horn, K., Erhardt, F., Fahlbusch, R., Pickardt, C. R., von Werder, K., and Scriba, P. C., 1976, Recurrent goiter, hyperthyroidism, galactorrhea, and amenorrhea due to a thyrotropin and prolactin-producing pituitary tumor, J. Clin. Endocrinol. Metab. 43:137–143.PubMedCrossRefGoogle Scholar
  146. 146.
    Sandler, R., 1976, Recurrent hyperthyroidism in an acromegalic patient previously treated with proton beam irradiation: Graves’ disease as probable etiology based on follow-up observations, J. Clin. Endocrinol. Metab. 42:163–168.PubMedCrossRefGoogle Scholar
  147. 147.
    Gerstner, J. B., and Caplan, R. H., 1976, Hyperthyroidism with normal concentrations of total serum thyroxine and triiodothyronine, J. Clin. Endocrinol. Metab. 42:64–69.PubMedCrossRefGoogle Scholar
  148. 148.
    Horwitz, D. L., and Refetoff, S., 1977, Graves’ disease associated with familial deficiency of thyroxine-binding globulin, J. Clin. Endocrinol. Metab. 44:242–247.PubMedCrossRefGoogle Scholar
  149. 149.
    Kusakabe, T., Yoshida, M., and Nishikawa, M., 1976, Thyrotoxic periodic paralysis: A peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels, J. Clin. Endocrinol. Metab. 43:730–740.PubMedCrossRefGoogle Scholar
  150. 150.
    Takeda, R., Morimoto, S., Uchida, K., and Miyamori, I., 1976. Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotoxic periodic paralysis, Acta Endocrinol. 82:715–727.PubMedGoogle Scholar
  151. 151.
    Peterson, D. M., Bounds, J. V., Jr., and Karnes, W. E., 1976, Clinical observations on thyrotoxicosis coexisting with myotonic dystrophy, Mayo Clin. Proc. 51:176–179.PubMedGoogle Scholar
  152. 152.
    Swaminathan, R., Segall, N. H., Chapman, C., and Morgan, D. B., 1976, Red-blood-cell composition in thyroid disease, Lancet 2:1382–1385.PubMedCrossRefGoogle Scholar
  153. 153.
    Auton, J. A., Barragry, J. M., Carter, N. D., Morris, D. V., and Cohn, R. D., 1976, Rapid diagnosis of thyroid disease using carbonic-anhydrase immunoassay, Lancet 2:1385–1387.PubMedCrossRefGoogle Scholar
  154. 154.
    Imura, H., Seino, Y., Ikeda, M., Taminato, T., Miyamoto, Y., and Goto, Y., 1976, Impaired plasma insulin response to arginine in hyperthyroidism, Diabetes 25:961–968.PubMedCrossRefGoogle Scholar
  155. 155.
    Shima, K., Sawazaki, N., Tanaka, R., Morishita, S., Tarui, S., and Nishikawa, M., 1976, The pancreatic alpha and beta cells responses to l-arginine and insulin-induced hypoglycaemia in hyperthyroidism, Acta Endocrinol. 83:114–122.PubMedGoogle Scholar
  156. 156.
    Kannan, C., Akbar, M., Begum, F., Dwarakanathan, A., and Burke, G., 1976, Dissociation between TSH and prolactin dynamics in treated thyrotoxicosis, Clin. Endocrinol. 5:331–340.CrossRefGoogle Scholar
  157. 157.
    Onishi, T., Itoh, K. F., Miyai, K., Izumi, K., Shima, K., and Kumahara, Y., 1976, Prolactin response to arginine in normal subjects and in patients with hyperthyroidism, J.Clin. Endocrinol. Metab. 42:148–151.CrossRefGoogle Scholar
  158. 158.
    Seino, Y., Matsukara, S., Miyamoto, Y., Goto, Y., Taminato, T., and Imura, H., 1976, Hypergastrinemia in hyperthyroidism,J. Clin. Endocrinol. Metab. 43:852–855.PubMedCrossRefGoogle Scholar
  159. 159.
    Coulombe, P., Dussault, J. H., and Walker, P., 1976, Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism, Metabolism 25:973–979.PubMedCrossRefGoogle Scholar
  160. 160.
    Coulombe, P., Dussault, J. H., Latarte, J., and Simard, S. J., 1976, Catecholamines metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyrodism, J. Clin. Endocrinol. Metab. 42:125–131.PubMedCrossRefGoogle Scholar
  161. 161.
    Carter, D. J., and Heath, D. A., 1977, The effect of treatment of hyper- and hypothyroidism on urinary excretion of cyclic adenosine 3′,5′-monophosphate, Acta Endocrinol. 84:542–547.PubMedGoogle Scholar
  162. 162.
    Mundy, G. R., Shapiro, J. L., Bandelin, J. G., Canalis, E. M., and Raisz, L., 1976, Direct stimulation of bone resorption by thyroid hormones,J. Clin. Invest. 58:529–534.PubMedCrossRefGoogle Scholar
  163. 163.
    Tougaard, L., 1976, The degree of bone mineralization in hyperthyroidism estimated from the phosphorus to hydroxyproline ratio in bone, Acta Endocrinol. 81:482–486.PubMedGoogle Scholar
  164. 164.
    Burman, K. D., Monchik, J. M., Earll, J. M., and Wartofsky, L., 1976, Ionized and total serum calcium and parathyroid hormone in hyperthyroidism, Ann. Intern. Med. 84:668–671.PubMedGoogle Scholar
  165. 165.
    May, P., and Levy, R. P., 1976, Thyrotoxicosis associated with renal tubular acidosis and acute pancreatitis: A case report, Ann. Intern. Med. 84:569–570.PubMedGoogle Scholar
  166. 166.
    Velentzas, C., Oreopoulos, D. G., From, G., Porret, B., and Rapoport, A., 1977, Vitamin-D levels in thyrotoxicosis, Lancet 1:370–371.PubMedCrossRefGoogle Scholar
  167. 167.
    Kasai, K., Suzuki, H., Kikuchi, T., Ieiri, T., Takemura, Y., and Shimada, S.-L, 1976, Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide, Endocrinol. Jpn. 23:347–354.PubMedCrossRefGoogle Scholar
  168. 168.
    Turner, J. G., Brownlie, B. E. W., Sadler, W. A., and Jensen, C. H., 1976, An evaluation of lithium as an adjunct to Carbimazole treatment in acute thyrotoxicosis, Acta Endocrinol. 83:86–92.PubMedGoogle Scholar
  169. 169.
    Boehm, T. M., Burman, K. D., and Wartofsky, L., 1976, Synergystic effects of lithium (Li) and iodine (I) in the treatment of hyperthyroidism (HT), Program Endocrine Soc, p. 366.Google Scholar
  170. 170.
    Spaulding, S. W., Burrow, G. N., Ramey, J. N., and Donabedian, R. K., 1977, Effect of increased iodide intake on thyroid function in subjects on chronic lithium therapy, Acta Endocrinol. 84:290–296.PubMedGoogle Scholar
  171. 171.
    Burman, K. D., Dimond, R. C., Earll, J. M., Wright, F. D., and Wartofsky, L., 1976, Sensitivity to lithium in treated Graves’ disease: Effects on serum T4, T3, and reverse T3 , J. Clin. Endocrinol. Metab. 43:606–613.PubMedCrossRefGoogle Scholar
  172. 172.
    Toft, A. D., Irvine, W. J., Mcintosh, D., MacLeod, D. A. D., Seth, J., Cameron, E. H. D., and Lidgard, G. P., 1976, Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy, J.Clin. Endocrinol. Metab. 43:1312–1316.CrossRefGoogle Scholar
  173. 173.
    Toft, A. D., Irvine, W. J., and Campbell, R. W. F., 1976, Assessment by continuous cardiac monitoring of minimum duration of preoperative propranolol treatment in thyrotoxic patients, Clin. Endocrinol. 5:195–198.CrossRefGoogle Scholar
  174. 174.
    Ortigosa, J. L., Mendoza, F. A., Argote, R., Garcia, G., Cervantes, C., and Parra, A., 1976, Propranolol effect on plasma glucose, free fatty acid, insulin, and growth hormone in Graves’ disease, Metabolism 25:1201–1207.PubMedCrossRefGoogle Scholar
  175. 175.
    Eriksson, M., Rubenfeld, S., Garber, A. J., and Kohler, P. O., 1977, Propranolol does not prevent thyroid storm, N. Engl. J. Med. 296:263–264.PubMedCrossRefGoogle Scholar
  176. 176.
    Bremner, W. F., Spencer, C. A., Ratcliffe, W. A., Greig, W. R., and Ratcliffe, J. G., 1976, The assessment of 125I treatment of thyrotoxicosis, Clin. Endocrinol. 5:225–234.CrossRefGoogle Scholar
  177. 177.
    McDougall, I. R., and Greig, W. R., 1976, 125I therapy in Graves’ disease: Long-term results in 355 patients, Ann. Intern. Med. 85:720–723.PubMedGoogle Scholar
  178. 178.
    Malone, J. F., and Cullen, M. J., 1976, Two mechanisms for hypothyroidism after 131I therapy, Lancet 2:73–75.PubMedCrossRefGoogle Scholar
  179. 179.
    Creutzig, H., Kallfelz, I., Haindl, J., Thiede, G., and Hundeshagen, H., 1976, Thyroid storm and iodine-131 treatment, Lancet 2:145.PubMedCrossRefGoogle Scholar
  180. 180.
    Stoffer, S. S., and Hamburger, J. I., 1976, Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy,J. Nucl. Med. 17:146–149.PubMedGoogle Scholar
  181. 181.
    Toft, A. D., Mcintosh, D., Cameron, E. H. D., Irvine, W. J., Seth, J., and Lidgard, G. P., 1976, Temporary hypothyroidism after surgical treatment of thyrotoxicosis, Lancet 2:817–821.PubMedCrossRefGoogle Scholar
  182. 182.
    Wilkin, T. J., Isles, T. E., Paterson, C. R., Crooks, J., and Beck, J. S., 1977, Post-thyroidectomy hypocalcaemia: A feature of the operation or the thyroid disorder?, Lancet 1:621–623.PubMedCrossRefGoogle Scholar
  183. 183.
    Crowley, W. F., Jr., Ridgway, E. C., Bough, E. W., Francis, G. S., Daniels, G. H., Kourides, I. A., Myers, G. S., and Maloof, F., 1977, Noninvasive evaluation of cardiac function in hypothyroidism, N. Engl. J. Med. 296:1–6.PubMedCrossRefGoogle Scholar
  184. 184.
    Yamada, T., Tsukui, T., Ikejiri, K., Yukimura, Y., and Kotani, M., 1976, Volume of sella turcica in normal subjects and in patients with primary hypothyroidism and hyperthyroidism, J.Clin. Endocrinol. Metab. 42:817–822.PubMedCrossRefGoogle Scholar
  185. 185.
    Vagenakis, A. G., Dole, K., and Braverman, L. E., 1976, Pituitary enlargement, pituitary failure, and primary hypothyroidism, Ann. Int. Med. 85:195–198.PubMedGoogle Scholar
  186. 186.
    Favus, M. J., Schneider, A. B., Stachura, M. E., Arnold, J. E., Ryo, U. Y., Pinsky, S. M., Colman, M., Arnold, M. J., and Frohman, L. A., 1976, Thyroid cancer occurring as a late consequence of head-and-neck irradiation, N. Engl. J. Med. 294:1019–1025.PubMedCrossRefGoogle Scholar
  187. 187.
    Schneider, A. B., Favus, M. J., Stachura, M. E., Arnold, M. J., and Frohman, L. A., 1977, Salivary gland neoplasms as a late consequence of head and neck irradiation, Ann. Int. Med. 87:160–164.PubMedGoogle Scholar
  188. 188.
    McConahey, W. M., and Hayles, A. B., 1976, Radiation and thyroid neoplasia, Ann. Intern. Med. 84:749–750.PubMedGoogle Scholar
  189. 189.
    Busnardo, B., Vangelista, R., Girelli, M. E., Bui, F., and Lazzi, C., 1976, TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma,J. Clin. Endocrinol. Metab. 42:901–906.PubMedCrossRefGoogle Scholar
  190. 190.
    McCowen, K. D., Adler, R. A., Ghaed, N., Verdon, T., and Hofeldt, F. D., 1976, Low dose radio iodide thyroid ablation in postsurgical patients with thyroid cancer, Am. J. Med. 61:52–58.PubMedCrossRefGoogle Scholar
  191. 191.
    Mazzaferri, E. L., Young, R. L., Oertel, J. E., Kemmerer, W. T., and Page, C. P., 1977, Papillary thyroid carcinoma: The impact of therapy in 576 patients, Medicine 56:171–196.PubMedCrossRefGoogle Scholar
  192. 192.
    Holt, P. J. A., Lazarus, J., and Marks, R., 1976, The epidermis in thyroid disease, Br. J. Dermatol. 95:513–518.PubMedCrossRefGoogle Scholar
  193. 193.
    Shenkman, L., and Bottone, E. J., 1976, Antibodies to Yersinia enterocolitica in thyroid disease, Ann. Intern. Med. 85:735–739.PubMedGoogle Scholar
  194. 194.
    Bech, K., Nerup, J., and Larsen, J. H., 1977, Yersinia enterocolitica infection and thyroid diseases, Acta Endocrinol. 84:87–92.PubMedGoogle Scholar
  195. 195.
    Konno, N., 1976, Serum thyrotropin response to thyrotropin-releasing hormone and free thyroid hormone indices in patients with familial thyroxine-binding globulin deficiency, Endocrinol. Jpn. 23:313–317.PubMedCrossRefGoogle Scholar
  196. 196.
    Abreau, C. M., Vagenakis, A. G., Roti, E., and Braverman, L. E., 1977, Clinical evaluation of a hemagglutination method for microsomal and thy-roglobulin antibodies in autoimmune thyroid disease, Ann. Clin. Lab. Sci. 7:73–78.PubMedGoogle Scholar
  197. 197.
    Ichikawa, Y., Saito, E., Abe, Y., Homma, M., Muraki, T., and Ito, K., 1976, Presence of TSH receptor in thyroid neoplasms, J. Clin. Endocrinol. Metab. 42:395–398.PubMedCrossRefGoogle Scholar
  198. 198.
    Ramirez, G., O’Neill, W., Jr., Jubiz, W., and Bloomer, H. A., 1976, Thyroid dysfunction in uremia: Evidence for thyroid and hypophyseal abnormalities, Ann. Intern. Med. 84:672–676.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1978

Authors and Affiliations

  • Kenneth A. Woeber
    • 1
  • Lewis E. Braverman
    • 2
  1. 1.Department of Medicine, Mt. Zion Hospital and Medical CenterUniversity of CaliforniaSan FranciscoUSA
  2. 2.Department of MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations